Question:

In which of the following scenarios is a PET/CT scan not indicated in the evaluation of a patient with breast cancer?

Show Hint

Reserve extensive systemic staging (CT, Bone scan, or PET/CT) strictly for breast cancer patients who are clinical Stage III or higher (T3, N2/N3), or those presenting with overt signs, symptoms, or lab abnormalities suggestive of distant metastatic spread.
Updated On: Sep 3, 2026
  • T2N0
  • T3N1
  • T1N1M1
  • T3N2
Show Solution
collegedunia
Verified By Collegedunia

The Correct Option is A

Solution and Explanation

Concept:
The clinician must determine the specific clinical stage of breast cancer for which an advanced $18\text{F-FDG}$ PET/CT scan is strictly not recommended by major oncological guidelines (like NCCN or ESMO) for initial routine staging.
This requires balancing the sensitivity of advanced imaging against the extremely low pre-test probability of finding distant metastases in early-stage disease.
Explanation:
• An $18\text{F-FDG}$ PET/CT scan is an incredibly sensitive functional and anatomical imaging modality utilized primarily to detect occult distant systemic metastases in oncology patients.

• However, because it is an expensive resource and exposes the patient to significant ionizing radiation, its clinical use must be thoroughly justified by the pre-test probability of actually finding metastatic disease based on the primary tumor's stage.

• For early-stage, operable breast cancer (specifically Stage I and Stage IIA, such as T1N0, T2N0, or T1N1mi), the statistical incidence of asymptomatic distant metastasis is exceedingly low (often less than $1-2\%$).

• Therefore, routine systemic staging with PET/CT, bone scans, or cross-sectional CT of the chest/abdomen/pelvis is explicitly NOT indicated for early-stage, asymptomatic breast cancer. Over-imaging in this population frequently leads to false-positive findings, which in turn precipitate unnecessary anxiety, delays in definitive surgical treatment, and invasive, morbid biopsies of benign incidentalomas.

• Systemic staging (using PET/CT or a combination of CT + Bone scan) is strongly indicated for patients presenting with locally advanced disease (Stage III and above). This includes patients with T3 or T4 disease, heavy regional nodal burden (N2, N3), inflammatory breast cancer, or if the patient exhibits specific clinical symptoms highly suggestive of systemic metastasis (e.g., focal bone pain, elevated alkaline phosphatase, or pulmonary symptoms).

• Option (A) T2N0 corresponds to Stage IIA disease without any axillary nodal involvement, a very low-risk scenario where advanced systemic imaging is entirely unwarranted.
Final Answer:
A PET/CT scan is not routinely indicated for a patient presenting with early-stage T2N0 breast cancer.
Was this answer helpful?
0
0

Top NEET SS Questions

View More Questions